Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

Presentation AHA 2016

FUnctional Testing Underlying REvascularization: The FUTURE trial

Presenter: Gilles Rioufol

November 15, 2016

News Conference News AHA 2016

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News AHA 2016

The ART of CABG: Bilateral Technique Associated With Similar Outcomes as Single Graft at 5 Years

Yael L. Maxwell

November 14, 2016

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Conference News AHA 2015

PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD

Todd Neale

November 10, 2015

News Conference News AHA 2015

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

L.A. McKeown

November 09, 2015

News Conference News AHA 2015

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

Todd Neale

November 09, 2015

News Conference News AHA 2015

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

Shelley Wood

November 08, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Conference News AHA 2014

Role of CTA in Survival Prediction, Resource Utilization Explored

November 17, 2014

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

News Conference News AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

Advertisement

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Arterial Revascularization Trial (ART)

FUnctional Testing Underlying REvascularization: The FUTURE trial

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

The ART of CABG: Bilateral Technique Associated With Similar Outcomes as Single Graft at 5 Years

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Role of CTA in Survival Prediction, Resource Utilization Explored

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content